GEORGIA ALLIANCE FOR BREAST CANCER
EIN: 47-0897591Peachtree Corners, GAZIP: 30092
G12 - Diseases, Disorders & Medical Disciplines501(c)(3)
Mission
GEORGIA ALLIANCE FOR BREAST CANCER MISSION IS TO ENGAGE WITH GEORGIA'S BREAST CANCER COMMUNITY TO INCREASE ACCESS TO CARE AND REDUCE DISPARITIES IN CANCER OUTCOMES.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $1.3M | $0 | $1.4M |
Compensation
Similar Organizations
ENDURING HEARTS INC
$1.4M revenueMarietta, GA
Same sector (G12)Very similar revenue ($1.4M vs $1.3M)Same state (Georgia)Comparable compensation levels
THE CANCER FOUNDATION INC
$1.4M revenueAthens, GA
Similar sector (G)Very similar revenue ($1.4M vs $1.3M)Same state (Georgia)Similar median compensation ($111k vs $110k)Similar size (13 vs 12 executives)
IAN'S FRIENDS FOUNDATION INC
$1.1M revenueAtlanta, GA
Same sector (G12)Similar revenue ($1.1M vs $1.3M)Same state (Georgia)
SPECTRUM AUTISM SUPPORT GROUP INC
$1.1M revenueSuwanee, GA
Similar sector (G)Similar revenue ($1.1M vs $1.3M)Same state (Georgia)Similar median compensation ($122k vs $110k)
AFLAC CHILDHOOD CANCER FOUNDATION INC
$1.4M revenueColumbus, GA
Similar sector (G)Very similar revenue ($1.4M vs $1.3M)Same state (Georgia)
THE OVARIAN CANCER INSTITUTE INC
$1M revenueAtlanta, GA
Similar sector (G)Similar revenue ($1M vs $1.3M)Same state (Georgia)Similar size (13 vs 12 executives)
SAVANNAH ASSOCIATION FOR THE BLIND
$814k revenueSavannah, GA
Similar sector (G)Comparable revenue ($814k vs $1.3M)Same state (Georgia)Similar median compensation ($105k vs $110k)Similar size (12 vs 12 executives)
MUCOLIPIDOSIS TYPE IV FOUNDATION INC
$1.1M revenueAtlanta, GA
Similar sector (G)Similar revenue ($1.1M vs $1.3M)Same state (Georgia)
READSOURCE INC
$1.1M revenueAtlanta, GA
Similar sector (G)Similar revenue ($1.1M vs $1.3M)Same state (Georgia)
ANGELS IN PARADISE INC
$1.9M revenueTyrone, GA
Similar sector (G)Comparable revenue ($1.9M vs $1.3M)Same state (Georgia)Similar median compensation ($110k vs $110k)
Data from IRS Form 990 filings (2023).